Shionogi’s Roche-partnered flu drug Xofluza won approval in Japan; Sun Pharma's key Halol plant was once again cited by the FDA; Chinese bispecific antibody developer EpimAb poached a top Novartis researcher for its CMO role; plus more pharma industry news from Asia.Original Article
FiercePharmaAsia—Shionogi’s flu drug, Sun’s key plant issue, EpimAb’s Novartis hire
